S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33

1Life Healthcare Stock Forecast, Price & News

-0.99 (-4.41 %)
(As of 09/24/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume1.58 million shs
Average Volume1.35 million shs
Market Capitalization$2.96 billion
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ONEM News and Ratings via Email

Sign-up to receive the latest news and ratings for 1Life Healthcare and its competitors with MarketBeat's FREE daily newsletter.

1Life Healthcare logo

About 1Life Healthcare

1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as employer sponsorship. Its membership model includes seamless access to digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2020, it had approximately 549,000 members in 13 markets in the United States; and 8,000 enterprise clients. The company was incorporated in 2002 and is headquartered in San Francisco, California.


1Life Healthcare (NASDAQ:ONEM) PT Lowered to $37.00 at Piper Sandler
1Life Healthcare (NASDAQ:ONEM) PT Lowered to $37.00 at Piper Sandler
September 24, 2021 |  americanbankingnews.com
1Life Healthcare (NASDAQ:ONEM)  Shares Down 5.6%
1Life Healthcare (NASDAQ:ONEM) Shares Down 5.6%
September 16, 2021 |  americanbankingnews.com
1Life Healthcare (NASDAQ:ONEM)  Shares Down 5.2%
1Life Healthcare (NASDAQ:ONEM) Shares Down 5.2%
September 2, 2021 |  americanbankingnews.com
One Medical Completes Acquisition of Iora Health
One Medical Completes Acquisition of Iora Health
September 1, 2021 |  finance.yahoo.com
One Medical Appoints Mary Ann Tocio to Board of Directors
One Medical Appoints Mary Ann Tocio to Board of Directors
September 1, 2021 |  finance.yahoo.com
Considering Retiring? Try a Sabbatical Instead
Considering Retiring? Try a Sabbatical Instead
August 24, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

2.51 out of 5 stars

Medical Sector

106th out of 1,351 stocks

Offices & Clinics Of Medical Doctors Industry

1st out of 11 stocks

Analyst Opinion: 4.4Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

1Life Healthcare (NASDAQ:ONEM) Frequently Asked Questions

Is 1Life Healthcare a buy right now?

15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for 1Life Healthcare in the last twelve months. There are currently 2 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" 1Life Healthcare stock.
View analyst ratings for 1Life Healthcare
or view top-rated stocks.

What stocks does MarketBeat like better than 1Life Healthcare?

Wall Street analysts have given 1Life Healthcare a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but 1Life Healthcare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is 1Life Healthcare's next earnings date?

1Life Healthcare is scheduled to release its next quarterly earnings announcement on Tuesday, November 9th 2021.
View our earnings forecast for 1Life Healthcare

How were 1Life Healthcare's earnings last quarter?

1Life Healthcare, Inc. (NASDAQ:ONEM) issued its earnings results on Tuesday, August, 3rd. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.18) by $0.12. The company earned $120.42 million during the quarter, compared to the consensus estimate of $115.63 million. 1Life Healthcare had a negative trailing twelve-month return on equity of 20.62% and a negative net margin of 22.60%. The firm's revenue was up 54.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.24) earnings per share.
View 1Life Healthcare's earnings history

How has 1Life Healthcare's stock been impacted by COVID-19?

1Life Healthcare's stock was trading at $24.30 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ONEM stock has decreased by 11.7% and is now trading at $21.45.
View which stocks have been most impacted by COVID-19

What guidance has 1Life Healthcare issued on next quarter's earnings?

1Life Healthcare issued an update on its FY 2021 earnings guidance on Wednesday, August, 25th. The company provided EPS guidance of for the period. The company issued revenue guidance of $475 million-$485 million, compared to the consensus revenue estimate of $482.10 million.

What price target have analysts set for ONEM?

15 equities research analysts have issued 1-year price targets for 1Life Healthcare's stock. Their forecasts range from $31.00 to $63.00. On average, they expect 1Life Healthcare's stock price to reach $44.27 in the next twelve months. This suggests a possible upside of 106.4% from the stock's current price.
View analysts' price targets for 1Life Healthcare
or view top-rated stocks among Wall Street analysts.

Who are 1Life Healthcare's key executives?

1Life Healthcare's management team includes the following people:
  • Mr. Amir Dan Rubin MBA, Chair, CEO & Pres (Age 51, Pay $1.58M)
  • Mr. Bjorn B. Thaler, Chief Financial Officer (Age 44, Pay $828.4k)
  • Ms. Kimber D. Lockhart, Chief Technology Officer (Age 34, Pay $760.2k) (LinkedIn Profile)
  • Rose Salzwedel, Director of Investor Relations
  • Ms. Lisa A. Mango, Gen. Counsel & Corp. Sec. (Age 53) (LinkedIn Profile)
  • Dr. Andrew S. Diamond M.D., Ph.D., Chief Medical Officer (Age 50)

What is Amir Dan Rubin's approval rating as 1Life Healthcare's CEO?

98 employees have rated 1Life Healthcare CEO Amir Dan Rubin on Glassdoor.com. Amir Dan Rubin has an approval rating of 71% among 1Life Healthcare's employees.

What other stocks do shareholders of 1Life Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 1Life Healthcare investors own include Teladoc Health (TDOC), Advanced Micro Devices (AMD), Fastly (FSLY), Etsy (ETSY), Livongo Health (LVGO), NVIDIA (NVDA), The Boeing (BA), Alibaba Group (BABA), The Walt Disney (DIS) and DocuSign (DOCU).

When did 1Life Healthcare IPO?

(ONEM) raised $262 million in an IPO on Friday, January 31st 2020. The company issued 17,500,000 shares at $14.00-$16.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Allen & Company LLC, Citigroup, Piper Jaffray, Wells Fargo Securities, William Blair, Baird and SunTrust Robinson Humphrey were co-managers.

What is 1Life Healthcare's stock symbol?

1Life Healthcare trades on the NASDAQ under the ticker symbol "ONEM."

Who are 1Life Healthcare's major shareholders?

1Life Healthcare's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (6.44%), Oak Management Corp (0.00%), Jackson Square Partners LLC (3.85%), ARK Investment Management LLC (2.37%), State Street Corp (1.56%) and Redmile Group LLC (1.21%). Company insiders that own 1Life Healthcare stock include Amir Dan Rubin, Andrew S Diamond, Bjorn B Thaler, David P Kennedy, Holmes Kalen, Kimber D Lockhart, Kimber D Lockhart, Lisa A Mango and Lisa A Mango.
View institutional ownership trends for 1Life Healthcare

Which major investors are selling 1Life Healthcare stock?

ONEM stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Invesco Ltd., Susquehanna International Group LLP, Laurion Capital Management LP, Citadel Advisors LLC, First Trust Advisors LP, Walleye Trading LLC, and Jump Financial LLC. Company insiders that have sold 1Life Healthcare company stock in the last year include Amir Dan Rubin, Andrew S Diamond, Bjorn B Thaler, David P Kennedy, Holmes Kalen, Kimber D Lockhart, and Lisa A Mango.
View insider buying and selling activity for 1Life Healthcare
or view top insider-selling stocks.

Which major investors are buying 1Life Healthcare stock?

ONEM stock was bought by a variety of institutional investors in the last quarter, including Oak Management Corp, ARK Investment Management LLC, Redmile Group LLC, Vanguard Group Inc., Macquarie Group Ltd., Jackson Square Partners LLC, State Street Corp, and Ardevora Asset Management LLP.
View insider buying and selling activity for 1Life Healthcare
or or view top insider-buying stocks.

How do I buy shares of 1Life Healthcare?

Shares of ONEM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is 1Life Healthcare's stock price today?

One share of ONEM stock can currently be purchased for approximately $21.45.

How much money does 1Life Healthcare make?

1Life Healthcare has a market capitalization of $2.96 billion and generates $380.22 million in revenue each year. The company earns $-88,720,000.00 in net income (profit) each year or ($0.67) on an earnings per share basis.

How many employees does 1Life Healthcare have?

1Life Healthcare employs 1,957 workers across the globe.

What is 1Life Healthcare's official website?

The official website for 1Life Healthcare is www.onemedical.com.

Where are 1Life Healthcare's headquarters?

1Life Healthcare is headquartered at One Embarcadero Center Suite 1900, San Francisco CA, 94111.

How can I contact 1Life Healthcare?

1Life Healthcare's mailing address is One Embarcadero Center Suite 1900, San Francisco CA, 94111. The company can be reached via phone at 415-814-0927 or via email at [email protected].

This page was last updated on 9/26/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.